- About the IMB
About the IMB
|IMB Director Professor Brandon Wainwright|
|IMB Deputy Director (Systems & Administration) Dr Ian Taylor|
|IMB Deputy Director (Research) Professor Jenny Stow
|IMB Deputy Director (Advancement) Amanda Whelan
The University of Queensland's Institute for Molecular Bioscience (IMB) is recognised nationally and internationally as one of Australia's leading centres for molecular bioscience research.
It was established in 2000 as an amalgamation of UQ's Centre for Molecular and Cellular Biology and the Drug Design and Development Centre, and is housed in the $105 million Queensland Bioscience Precinct, construction of which was finished in 2003.
The IMB is a multidisciplinary research institute with a range of strategic programs in mammalian systems biology, supported by some of the finest facilities in the region.
The IMB has four major divisions:
Genomics and Computational Biology,
Molecular Genetics and Development,
Molecular Cell Biology, and
Chemistry and Structural Biology.
It houses around 400 research staff and research students with an annual budget in the order of around AUD$80m.
The IMB is committed to improving quality of life for all by pursuing discoveries through fundamental research, inventing biotechnologies, and advancing cures for diseases.
More specifically, IMB's major research themes are personalised medicine, drug discovery and biotechnology.
Pivotal to the IMB's success in these research endeavours is its involvement in various strategic programs aimed at furthering Australia's research infrastructure and scientific capital.
Supporting leading-edge science research in developing technologies and fostering collaborative efforts with other research institutions and industry, these programs ensure the opportunities of the biotechnology revolution are translated into benefits for our society.
IMB is a core partner in two Australian Research Council Biotechnology Centres of Excellence (COE) - the COE in Biotechnology and Development and the Australian Research Council Centre of Excellence in Bioinformatics. IMB researchers are core partners in the Australasian Invasive Animal CRC.
The Institute houses the Advanced Cryo-Electron Microscopy Laboratory - a major node of the Australian Microscopy & Microanalysis Research Facility (AMMRF), the 900 MHz NMR of the Queensland NMR Network and the ACRF Cancer Biology Imaging Facility funded by the Australian Cancer Research Foundation.
The Institute's research outcomes are protected and commercialised by the University-owned technology transfer corporation Uniquest. This company works in tandem with the IMB scientists to achieve effective translation of research discoveries and technologies into high-value applied and commercial outcomes.
The IMB is located with CSIRO in the Queensland Bioscience Precinct, the largest integrated bioscience research complex in Australia. The QBP is located at The University of Queensland in St Lucia, Brisbane, Australia.
|About the IMB section|